What are the Challenges in Targeting KRAS Mutations?
Targeting KRAS mutations has been difficult due to the structure of the K-Ras protein, which lacks suitable binding pockets for small molecule inhibitors. Additionally, the high affinity of K-Ras for GTP/GDP makes it challenging to develop effective inhibitors. Despite these challenges, recent advances have led to the development of some promising KRAS inhibitors.
